Logo image of TNXP

TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Analyst Ratings

NASDAQ:TNXP - Nasdaq - US8902608392 - Common Stock - Currency: USD

40.65  +2.24 (+5.83%)

After market: 40.2 -0.45 (-1.11%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to TNXP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 414.8. This target is 920.42% above the current price.
TNXP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TNXP.
In the previous month the buy percentage consensus was at a similar level.
TNXP was analyzed by 7 analysts. More opinions would make the average more meaningful.
TNXP Historical Analyst RatingsTNXP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 40.6550.5071.40414.801,155.00 - 24.23% 75.65% 920.42% 2,741.33%
TNXP Current Analyst RatingTNXP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-03-20 Noble Capital Markets Reiterate Outperform -> Outperform
2024-07-22 Alliance Global Partners Maintains Buy -> Buy
2024-02-28 Dawson James Initiate Buy
2023-08-01 Alliance Global Partners Maintains Buy -> Buy
2023-06-02 Alliance Global Partners Maintains Buy -> Buy
2023-01-12 Alliance Global Partners Reiterate Buy
2022-04-18 Noble Capital Markets Initiate Outperform